To date, all studies evaluating minimally invasive interventions for treatment of venous insufficiency of the GSV have been comparing the techniques to the traditional method of stripping (under spinal or general anesthesia, without using duplex…
ID
Source
Brief title
Condition
- Vascular therapeutic procedures
- Venous varices
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary studyparameter will be a clinical recurrence measured by duplex
echography at 3,12 and 24 months after intervention.
Secondary outcome
Secondary study parameters will be quality of life as measured by different
questionnaires. This study will use the SF-36, EuroQol-5, Aberdeen varicose
Vein Questionnaire (AVVQ) and the Pain Disability Index for measuring quality
of life. Questionnaires will be completed before and 1, 3, 12, 24 months after
intervention. Another secondary parameter which will be evaluated is the cost
of the intervention.
Background summary
Chronic venous insufficiency (CVI) of the lower extremities is a common
disorder and occurs in 15% of men and 35% of women (1-3 Callam, Evans,
Margolis). The effect of venous insufficiency on quality of life is substantial
and comparable to chronic diseases such as arthritis, diabetes and
cardiovascular diseases (4 Andreozzi). The venous ulcer of the lower
extremities has a prevelence of 1% (5 Nelzen). The medical costs of CVI are
high. Almost 2% of England's medical costs are due to CVI. The signs and
symptoms of venous disease cause a decline in patients quality of life and
account for a high level of absenteeism. Recently it was shown that in standing
professions venous symptoms occur in more than 80% of workers. In 7% of the
cases this led to absenteeism (6 Krijnen). The gold standard for treatment of
CVI of the greater saphenous vein (GSV) is the so-called stripping of the
veins (7 Bos). In recent years, however, new techniques are developed and
existing techniques have been further developed in the treatment of CVI of the
GSV. The preferred treatment of CVI of the GSV is open for discussion ever
since.
Study objective
To date, all studies evaluating minimally invasive interventions for treatment
of venous insufficiency of the GSV have been comparing the techniques to the
traditional method of stripping (under spinal or general anesthesia, without
using duplex imaging, with a success rate of 70-78% after 1 -3 Years) (7 Bos).
When the stripping is preformed by means of duplex imaging and local, tumescent
anesthesia, a significantly higher success rate of 90-98% is achieved after
6-12 months (15 Rasmussen). The available studies of the modern stripping and
minimally invasive techniques for the treatment of CVI of the VSM are small.
Sufficient long follow-up to illustrate superiority of one of the techniques is
lacking. Also, most techniques are evaluated only by clinical recurrence
measured with duplex echography and rarely by means of changes in patients
quality of life. Until now, it is unclear which is the most succesful
intervention in treating venous insufficiency of the GSV. This research will
answer this question by comparing head to head two of the most widely used
modern techniques in a prospective randomized study.
Study design
Prospective, randomized non-blinded, multicenter intervention study in which
three are already widely used techniques (modern stripping with crossectomy,
modern stripping without crossectomy and radiofrequency ablation) are compared
in terms of recurrence, quality of life and cost effectiveness for two years.
Intervention
Patients will be enrolled in the outpatient clinic for vascular surgery.
Participating patients diagnosed with venous insuffiency of the GSV according
to the CEAP classification (appendix protocol) will be randomised in one of
three intervention groups (modern stripping with crossectomy, modern stripping
without crossectomy and radiofrequency ablation). Modern stripping is preformed
under local, tumescent anesthesia. The saphenofemoral junction will be searched
by duplex, so the incision and dissection to a minimum. The GSV will be
approched and stripped via a small incision in the groin. By using modern
stripping equipment, a second incision at knee level is abbandoned. The
optional crossectomy will be standardized. The third minimally invasive
intervention will be conducted with the VNUS ClosureFAST* Catheter without an
incision in the groin. The VNUS ClosureFAST* catheter for the treatment of
venous reflux delivers radiofrequency energy to a heating element to heat and
contract the collagen within the vein walls and cause the shrinkage and
collapse of the vessel.
Study burden and risks
The research will have little effect on the participants. Patients will recieve
one of two already wideley used treatments for treating venous insufficiency of
the GSV. After the intervention patients will enter a non-invasive follow-up
consisting of duplex examinations and completing questionnaires at fixed
intervals.
Henri Dunantstraat 5
Heerlen
NL
Henri Dunantstraat 5
Heerlen
NL
Listed location countries
Age
Inclusion criteria
-Patients with primary varicosity of the GSV, between age 18-80 year.
-CEAP 2-4(Appendix B/VI), without deep vein insufficiency.
-Minimum distance between skin and the GSV in the first 20 cm from the SFJ >5mm.
-Minimum length of to be treated GSV 10cm.
-GSV on one side will be treated in the case of bilateral insufficiency.
-GSV will be treated only in the case of solitary GSV insufficiency.
-Patients treated by experienced surgeon/center.
Exclusion criteria
-Age <18 years or >80 years.
-Deep vein insufficiency in the same extremity (duplex verified).
-Previous thrombosis of the affected limb (secondary thrombosis)
-Tortuosity of the GSV, double GSV system.
-Superficial veins with a distance of <5mm to the skin surface ( RF cannot be applied), as measured at echo-duplex.
-Patients with double GSV's and/or lateral accessory insufficient branch.
-Earlier operation of the GSV with crossectomy/stripping(recurrency).
-Operated for small saphenous vein (SSV) incompetence the last 3 months.
-Known ABI <0,9 or history of intermittent claudication or peripheral pulselessness (clinical examination)in either extremity.
-Patients with active malignancy.
-Patients with other known medical condition that contradict any of the treatments in the study.
-History of CVA/central nervous system disease
-Pregnancy
-Patients treated with coumarine derivates, if cannot be interrupted during treatment(switched to a LMWH).
-Pacemaker
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL36200.096.11 |